First Time Loading...

BioCryst Pharmaceuticals Inc
NASDAQ:BCRX

Watchlist Manager
BioCryst Pharmaceuticals Inc Logo
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
Watchlist
Price: 6.07 USD -0.98% Market Closed
Updated: May 28, 2024

BioCryst Pharmaceuticals Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioCryst Pharmaceuticals Inc
Depreciation & Amortization Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
Depreciation & Amortization
$1.6m
CAGR 3-Years
30%
CAGR 5-Years
15%
CAGR 10-Years
20%
Abbvie Inc
NYSE:ABBV
Depreciation & Amortization
$8.6B
CAGR 3-Years
2%
CAGR 5-Years
37%
CAGR 10-Years
26%
Gilead Sciences Inc
NASDAQ:GILD
Depreciation & Amortization
$2.7B
CAGR 3-Years
20%
CAGR 5-Years
14%
CAGR 10-Years
18%
Amgen Inc
NASDAQ:AMGN
Depreciation & Amortization
$4.6B
CAGR 3-Years
9%
CAGR 5-Years
18%
CAGR 10-Years
12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Depreciation & Amortization
$196m
CAGR 3-Years
21%
CAGR 5-Years
19%
CAGR 10-Years
14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Depreciation & Amortization
$435.6m
CAGR 3-Years
21%
CAGR 5-Years
22%
CAGR 10-Years
26%

See Also

What is BioCryst Pharmaceuticals Inc's Depreciation & Amortization?
Depreciation & Amortization
1.6m USD

Based on the financial report for Mar 31, 2024, BioCryst Pharmaceuticals Inc's Depreciation & Amortization amounts to 1.6m USD.

What is BioCryst Pharmaceuticals Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
20%

Over the last year, the Depreciation & Amortization growth was 1%. The average annual Depreciation & Amortization growth rates for BioCryst Pharmaceuticals Inc have been 30% over the past three years , 15% over the past five years , and 20% over the past ten years .